Bujang N-N-A, Lee Y-J, Mohd-Zain S-A-S, Aris J-H, Md-Yusoff F-A, Suli Z, et al. Factors associated with colorectal cancer screening via immunochemical fecal occult blood test in an average-risk population from a multiethnic, middle-income setting. JCO Glob Oncol. 2021;7(1):333–41.
Jiang H, Guo W, Huang K, Jiang H, Zhang R, Hu H, et al. Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2.Abdom Radiol. 2021;46(7):3227–37.
Wong MC, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955–66. e61.
Deo S, Kumar S, Bhoriwal S, Shukla N, Sharma A, Thulkar S, et al. Colorectal cancers in low-and middle-income countries—Demographic pattern and clinical profile of 970 patients treated at a tertiary care cancer center in India. JCO Global Oncol. 2021;7:1110–5.
Article CAS PubMed Google Scholar
Cao Y, Zhao G, Yuan M, Liu X, Ma Y, Cao Y, et al. KCNQ5 and C9orf50 methylation in stool DNA for early detection of colorectal cancer. Front Oncol. 2021;10: 621295.
Article PubMed PubMed Central Google Scholar
Njor SH, Andersen B, Friis-Hansen L, de Haas N, Linnemann D, Nørgaard H, et al. The optimal cut-off value in fit-based colorectal cancer screening: An observational study. Cancer Med. 2021;10(5):1872–9.
Article CAS PubMed PubMed Central Google Scholar
Ramazani AA, Norozi E, AmirabadiZadeh H, Ehteshampour AR, Salehiniya H. Predictors of colorectal cancer screening participation in Southern Khorasan (Iran). J Gastrointest Cancer. 2021;52(1):187–91.
Article CAS PubMed Google Scholar
Wu X, Zhang Y, Hu T, He X, Zou Y, Deng Q, et al. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer. Mol Oncol. 2021;15(10):2702–14.
Article CAS PubMed PubMed Central Google Scholar
Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, et al. Microbial markers in colorectal cancer detection and/or prognosis. World J Gastroenterol. 2018;24(22):2327.
Article PubMed PubMed Central Google Scholar
Su W-C, Kao W-Y, Chang T-K, Tsai H-L, Huang C-W, Chen Y-C, et al. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer. Biosci Rep. 2021;41(1).
Wu Y, Yang X, Jiang G, Zhang H, Ge L, Chen F, et al. 5′-tRF-GlyGCC: A tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis. Genome medicine. 2021;13(1):1–12.
Buturovic S. Colonoscopy as a method of choice in the diagnosis of colorectal cancer. Acta Informatica Medica. 2014;22(3):164.
Article PubMed PubMed Central Google Scholar
Triantafillidis JK, Vagianos C, Malgarinos G. Colonoscopy in colorectal cancer screening: Current aspects. Indian J Surg Oncol. 2015;6:237–50.
Article PubMed PubMed Central Google Scholar
Zhang W, Xiao G, Chen J, Wang L, Hu Q, Wu J, et al. Electrochemical biosensors for measurement of colorectal cancer biomarkers. Anal Bioanal Chem. 2021;413(9):2407–28.
Article CAS PubMed Google Scholar
Lee K, Seo H, Choe S, Jeong S-Y, Park JW, Suh M, et al. Intentions to undergo primary screening with colonoscopy under the National Cancer Screening Program in Korea. PLoS ONE. 2021;16(2):e0247252.
Article CAS PubMed PubMed Central Google Scholar
Pellino G, Gallo G, Pallante P, Capasso R, De Stefano A, Maretto I, et al. Noninvasive biomarkers of colorectal cancer: Role in diagnosis and personalised treatment perspectives. Gastroenterology Res Pract. 2018;2018.
Peterse EF, Meester RG, de Jonge L, Omidvari A-H, Alarid-Escudero F, Knudsen AB, et al. Comparing the cost-effectiveness of innovative colorectal cancer screening tests. JNCI: J Natl Cancer Inst. 2021;113(2):154–61.
Liu W, Zhang R, Shu R, Yu J, Li H, Long H, et al. Study of the relationship between microbiome and colorectal cancer susceptibility using 16SrRNA sequencing. BioMed Res Int. 2020;2020.
De Almeida CV, Lulli M, di Pilato V, Schiavone N, Russo E, Nannini G, et al. Differential responses of colorectal cancer cell lines to Enterococcus faecalis’ strains isolated from healthy donors and colorectal cancer patients. J Clin Med. 2019;8(3):388.
Article PubMed PubMed Central Google Scholar
Zamani S, Taslimi R, Sarabi A, Jasemi S, Sechi LA, Feizabadi MM. Enterotoxigenic Bacteroides fragilis: A possible etiological candidate for bacterially-induced colorectal precancerous and cancerous lesions. Front Cell Infect Microbiol. 2020;9:449.
Article PubMed PubMed Central Google Scholar
Bao Y, Tang J, Qian Y, Sun T, Chen H, Chen Z, et al. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway. Cell Death Dis. 2019;10(9):1–14.
Lafuente Ibáñez de Mendoza I, Maritxalar Mendia X, Garcia de la Fuente AM, Quindos Andres G, Aguirre Urizar JM. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review. J Periodontal Res. 2020;55(1):13–22.
Rodríguez IT, Ballart JF, Pastor GC, Jorda EB, Val VA. Validation of a short questionnaire on frequency of dietary intake: Reproducibility and validity. Nutr Hosp. 2008;23(3):242–52.
Rezasoltani S, Sharafkhah M, Aghdaei HA, Mojarad EN, Dabiri H, Sepahi AA, et al. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer. J Microbiol Methods. 2018;155:82–8.
Article CAS PubMed Google Scholar
Collins J, Albert PS. Estimating diagnostic accuracy without a gold standard: A continued controversy. J Biopharm Stat. 2016;26(6):1078–82.
Pereira GdA, Louzada F, Barbosa VdF, Ferreira-Silva MM, Moraes-Souza H. A general latent class model for performance evaluation of diagnostic tests in the absence of a gold standard: An application to Chagas disease. Comput Math Methods Med. 2012;2012.
Pepe MS, Janes H. Insights into latent class analysis of diagnostic test performance. Biostatistics. 2007;8(2):474–84.
Qin J, Zhang B. Best combination of multiple diagnostic tests for screening purposes. Stat Med. 2010;29(28):2905–19.
Yu B, Zhou C, Bandinelli S. Combining multiple continuous tests for the diagnosis of kidney impairment in the absence of a gold standard. Stat Med. 2011;30(14):1712–21.
Article PubMed PubMed Central Google Scholar
Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2015;308(5):G351-G63.
Haghi F, Goli E, Mirzaei B, Zeighami H. The association between fecal enterotoxigenic B. fragilis with colorectal cancer. BMC Cancer. 2019;19(1):1–4.
Vacante M, Ciuni R, Basile F, Biondi A. Gut microbiota and colorectal cancer development: A closer look to the adenoma-carcinoma sequence. Biomedicines. 2020;8(11):489.
Article CAS PubMed PubMed Central Google Scholar
Khan Z, Siddiqui N, Saif MW. Enterococcus faecalis infective endocarditis and colorectal carcinoma: Case of new association gaining ground. Gastroenterology Res. 2018;11(3):238.
Article PubMed PubMed Central Google Scholar
Liu X-b, Gao Z-y, Sun C-t, Wen H, Gao B, Li S-b, et al. The potential role of P. gingivalis in gastrointestinal cancer: A mini review. Infectious Agents and Cancer. 2019;14(1):1–7.
Kim M, Lee S-T, Choi S, Lee H, Kwon SS, Byun JH, et al. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea. Sci Rep. 2020;10(1):1–10.
Purcell RV, Pearson J, Aitchison A, Dixon L, Frizelle FA, Keenan JI. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS ONE. 2017;12(2):e0171602.
Article PubMed PubMed Central Google Scholar
Oyeyemi SO, Braaten T, Licaj I, Lund E, Benjaminsen BK. Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: A population-based prospective study. BMC Cancer. 2018;18(1):1–11.
Luo W-P, Fang Y-J, Lu M-S, Zhong X, Chen Y-M, Zhang C-X. High consumption of vegetable and fruit colour groups is inversely associated with the risk of colorectal cancer: A case–control study. Br J Nutr. 2015;113(7):1129–38.
Article CAS PubMed Google Scholar
Morris JS, Bradbury KE, Cross AJ, Gunter MJ, Murphy N. Physical activity, sedentary behaviour and colorectal cancer risk in the UK Biobank. Br J Cancer. 2018;118(6):920–9.
Article PubMed PubMed Central Google Scholar
Khatatbeh MM, Jadallah KA, Bashtawy MA, Hamaydeh SA, Gharaibeh MA, Kanaan NB, et al. Factors associated with colorectal cancer among Jordanians: A case-control study. Asian Pacific Journal of Cancer Prevention: APJCP. 2018;19(2):577.
PubMed PubMed Central Google Scholar
Miles L. Physical activity and the prevention of cancer: A review of recent findings. Nutr Bull. 2007;32(3):250–82.
Zhou X-Y, Yan L, Wang L-L, Wang J. Association between physical activity and colorectal cancer risk and prognosis: A meta-analysis. Cancer Treat Res Commun. 2016;9:62–9.
Shaw E, Farris MS, Stone CR, Derksen JW, Johnson R, Hilsden RJ, et al. Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: A systematic review and meta-analysis. BMC Cancer. 2018;18(1):1–15.
Hannan LM, Jacobs EJ, Thun MJ. The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomark Prev. 2009;18(12):3362–7.
Luchtenborg M, White KK, Wilkens L, Kolonel LN, Le Marchand L. Smoking and colorectal cancer: Different effects by type of cigarettes? Cancer Epidemiol Biomark Prev. 2007;16(7):1341–7.
Peppone LJ, Hyland A, Moysich KB, Reid ME, Piazza KM, Purnell JQ, et al. Examining the association between cigarette smoking and colorectal cancer using historical case–control data. Cancer Epidemiol. 2009;33(3–4):182–8.
Article PubMed PubMed Central Google Scholar
Wei P-L, Lin S-Y, Chang Y-J. Cigarette smoking and colorectal cancer: From epidemiology to bench. J Exp Clin Med. 2011;3(6):257–61.
Lee S, Woo H, Lee J, Oh J-H, Kim J, Shin A. Cigarette smoking, alcohol co
Comments (0)